Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after breast neoadjuvant chemotherapy.
Chitalia R, Miliotis M, Jahani N, Tastsoglou S, McDonald ES, Belenky V, Cohen EA, Newitt D, Van't Veer LJ, Esserman L, Hylton N, DeMichele A, Hatzigeorgiou A, Kontos D.
Chitalia R, et al. Among authors: belenky v.
Commun Med (Lond). 2023 Mar 30;3(1):46. doi: 10.1038/s43856-023-00273-1.
Commun Med (Lond). 2023.
PMID: 36997615
Free PMC article.